There is 1 paper on apoB-containing particles in aging research: none in people yet, 1 review.
1 paper studies it5 more mention it1 finding
3 new papers in 30 daysSee all 6 papers on apoB-containing particles
Associations
1Premature coronary artery disease
upin humans1
1 study
Premature coronary artery disease
upin humans1
apoB-containing particles are associated with premature coronary artery disease in humans.
“This narrative review examines cumulative exposure to atherogenic apolipoprotein B (apoB)-containing particles as one major, modifiable pathway in atherosclerotic PCAD.”
Reviewcumulative exposure
Frontiers in cardiovascular medicine
Latest
4 papers in 12 monthsFrontiers in Cardiovascular Medicine
Atherogenic lipoprotein particles and premature coronary artery disease: from molecular mechanisms to precision prevention
ReviewMechanisms
AHA Scientific Sessions 2026 Abstract
Comparison of Lipoprotein(a) and Other Apolipoprotein B Containing Lipoproteins as Predictors of Major Adverse Cardiovascular Events in REDUCE-IT
Cohort study of 6,988 peopleApolipoprotein B
Frontiers in Cardiovascular Medicine
Remnant lipoproteins and remnant cholesterol in residual atherosclerotic cardiovascular risk
Frontiers in Cardiovascular Medicine
From particle count to residence time: a kinetic framework for atherogenic risk
CommentaryMechanisms
AHA Scientific Sessions 2025 Abstract
Triglyceride in different ApoB-containing lipoproteins and risk of coronary artery disease: particle type matters
Cohort study of 472,495 peopleCoronary artery disease
AHA Scientific Sessions 2025 Abstract
Eicosapentaenoic Acid Attenuates Oxidation of Lp(a) and other Atherogenic Lipoproteins by a Potential Scavenging Mechanism
Experiments in human cellsEicosapentaenoic acid